SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    Former GSK counsel joins CBD group Chill Brands

    By
    Home / Former GSK counsel joins CBD group Chill Brands

    A former counsel to some of the world’s largest brands, including GlaxoSmithKline and Colgate-Palmolive has joined the international CBD group Chill Brands.

    Scott Thompson has been appointed to Chill Brand’s board as an independent non-executive director. 

    As former general counsel intellectual property for Mars Inc. and assistant general counsel of Philip Morris Companies, Thompson has almost forty years of intellectual property law experience. He is recognised by the World Trademark Reporter as one of the top 300 trademark attorneys in the world. 

    Co-CEO and Founder of Chill Brands, Trevor Taylor, said: “We are excited to welcome Scott E. Thompson to Chill Brands and are confident in his ability to guide the Company as it becomes a global consumer packaged goods brand.

    “His appointment to the Board shows that we are serious about our commitment to corporate governance. When building a world class brand, you must have best in class experience, talent and leadership. We have all three in Scott E. Thompson.”

    Thompson added: “I am pleased to be joining the Chill Brands Board and look forward to working with the expert team they are building. 

    Read more: Chill Brands partners with US soccer league to offer CBD products

    “Chill is a powerful brand that has the potential to become a household name. It requires a robust strategy to protect its intellectual property and reach its true potential as a CPG [consumer packaged goods] company. 

    “As a non-executive director, my task now is to keep the team accountable and guide the company as it grows.”

    Thompson was most recently general counsel, intellectual property/marketing properties for Mars Inc., where he oversaw global intellectual property/marketing properties for all of the company’s businesses and enhanced the global licensing and compliance program for all Mars brands, including M&M’s World Stores.

    At GlaxoSmithKline, Thompson served as vice president, global trademarks, and as global head of a 50-person tri-location trademark department responsible for trademark, copyright, unfair competition, and internet and intranet matters for the world’s second-largest pharmaceutical and consumer healthcare company.

    At Colgate-Palmolive, he served as vice president and associate general counsel, where he managed the department responsible for global trademark, copyright, unfair competition, and Internet matters.

    Thompson also served as assistant general counsel at Philip Morris, where he was responsible for trademark, copyright, unfair competition, and advertising issues, and had jurisdiction over tobacco products worldwide and food, beer, clothing, and miscellaneous products outside of the US.

    Chill Brands has stated that the board is considering a share-based compensation package in relation to Thompson’s appointment.

    [activecampaign form=31]

    10 June 2026 · Berlin Sales end May 29

    European Cannabis
    Insights Summit

    From €216

    200+ industry leaders. Exclusive German market data. A half-day briefing for B2B operators in Europe's most important emerging cannabis market.

    Stephanie Price

    Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine ‘Game Theory’ focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on “Medical Cannabis Explained”.

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free